´ëÇÑÀ§¾ÏÇÐȸ 2023 À§¾Ï º¹¸·ÀüÀÌ ¿¬±¸ ½ÉÆ÷Áö¿ò : 2023-12-09
±³À°ÀÏÀÚ : 2023-12-09
±³À°Àå¼Ò : °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü 1F ´ë°´ç
±³À°ÁÖÁ¦ : 2023 À§¾Ï º¹¸·ÀüÀÌ ¿¬±¸ ½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ´ëÇÑÀ§¾ÏÇÐȸ
´ã´çÀÚ : ±èÁöÇý
¿¬¶ôó : 02-730-3760
À̸ÞÀÏ : kgca@kgca-i.or.kr
±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 10:20~10:25 Opening remarks ±èÁ¾ÇÑ(°í·Á´ëÇб³)
±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 10:25~10:30 Congratulatory remarks ·ù±Ù¿ø(´ëÇÑÀ§¾ÏÇÐȸ ÀÌ»çÀå)
±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 10:30~12:05 [ÁÂÀå] Plenary I: Issues for Intraperitoneal metastasis ÇÏÅ°æ/¹ÚÁß¹Î(ÇѾç´ëÇб³/Áß¾Ó´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 10:30~10:50 Plenary I: RECIST criteria and recent updates for response measurements ±èÁ¤¿ì(°í·Á´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 10:50~11:10 Plenary I: Assessment of Peritoneal Cancer Index ±èµ¿¿í(´Ü±¹´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 11:10~11:30 Plenary I: NK cell treatment for Intraperitoneal carcinomatosis °Á¤È(Immunisbio)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 11:30~11:50 Plenary I: Biomarker study for metastatic Gastric Cancer ÃÖÀ±¿µ(¼øõÇâ´ëÇб³)
Åä·Ð 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 11:50~12:05 Discussion ±ÇÀαÔ/ÀåÀ¯Áø/À±Á¾Çõ(¿¬¼¼´ëÇб³/°í·Á´ëÇб³/¼øõÇâ´ëÇб³)
±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 12:05~12:30 [ÁÂÀå] Special Lecture: Phoenix trial ·ù±Ù¿ø(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 12:05~12:30 Special Lecture: Treatment of Intraperitoneal Metastasis in Japan Hironori ishigami(The University of Tokyo)
½Ä»ç 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 12:30~13:30 Lunch .(.)
±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 13:30~14:45 [ÁÂÀå] Plenary II: Recent update and future perspectives for stage IV gastric cancer ÇãÈÆ/ÀÌÇÑÈ«(¾ÆÁÖ´ëÇб³/°¡Å縯´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 13:30~13:50 Plenary II: Recent updates for palliative chemotherapy ¿À»óö(°í·Á´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 13:50~14:10 Plenary II: Result of IPLUS trial and updates of PIPAC trial °¼ÒÇö(¼¿ï´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 14:10~14:30 Plenary II: Result of PIPS-GC PIb/II study and Introduction of PIPS-GC phase 3 trial ¼¿øÁØ(°í·Á´ëÇб³)
Åä·Ð 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 14:30~14:45 Discussion Áø¼ºÈ£/±èÇüÀÏ/¼ÛÁ¤È£(¿øÀڷº´¿ø/¿¬¼¼´ëÇб³/¾ÆÁÖ´ëÇб³)
ÈÞ½Ä 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 14:45~15:05 Coffee Break .(.)
±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 15:05~16:45 [ÁÂÀå] Plenary III: Sharing Experiences of Intraperitoneal Chemotherapy ±èÁøÁ¶/ÃÖ¼ºÀÏ(°¡Å縯´ëÇб³/°æÈñ´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 15:05~15:25 Plenary III: Experience of Intraperitoneal chemotherapy with PIPS-GC trial ±èÁ¾¿ø(Áß¾Ó´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 15:25~15:45 Plenary III: Experience of Palliative chemotherapy for Peritoneal metastasis ·ùÈÆ(¿¬¼¼´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 15:45~16:05 Plenary III: Experience of intraperitoneal chemotherapy, multiple cases ÀÌâ¹Î(°í·Á´ëÇб³)
±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 16:05~16:25 Plenary III: Conversion surgery after intraperitoneal chemotherapy for peritoneal metastasis ¹Ú±â¹ü(°æºÏ´ëÇб³)
Åä·Ð 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 16:25~16:45 Discussion ¹ÎÀç¼®/Á¤¹Ì¶õ/À̼¼Áø(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø/Àü³²´ëÇб³/ÀüºÏ´ëÇб³)
±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°´ç 16:45~17:00 Closing Celemony ±èÁ¾ÇÑ(°í·Á´ëÇб³)